Ayurvedic supportive therapy in the management of breast cancer

被引:3
作者
Dash, Manoj Kumar [1 ]
Joshi, Namrata [1 ]
Gautam, D. N. S. [1 ]
Jayakumar, Remya [1 ]
Tripathi, Y. B. [2 ]
机构
[1] BHU, IMS, Fac Ayurveda, Dept Rasa Shastra, Varanasi, Uttar Pradesh, India
[2] BHU, IMS, Fac Ayurveda, Dept Med Chem, Varanasi 221005, Uttar Pradesh, India
关键词
Breast cancer; Ayurveda formulations; Herbal; Food supplements; Lymphadenopathy; Supportive therapy; CELL-LINE; MEDICINE; CYTOTOXICITY; PREVENTION; BHASMA; LEAF; NANOPARTICLES; CHEMOTHERAPY; INHIBITORS; INDUCTION;
D O I
10.1016/j.hermed.2021.100490
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Introduction: Breast cancer is the second most common cancer among women. Initial signs of cancer start in the lymph nodes located under the arm, within the breast, and near the collarbone. Many promising remedies for breast cancer are included in Ayurveda, the Indian system of medicine. Nowadays, multi-targeted herbal drugs are used as an adjuvant therapy alongside conventional medicine in the management of this type of cancer. The present review concentrates on the available literature found in Ayurveda regarding plants and breast cancer. Methods: Web of Science, PubMed, Google Scholar were searched, resulting in 115 articles, as per the authors study criteria, by using keywords, breast cancer, and medicinal plants, then were able to aggregate 64 therapeutic targets from 35 different plant species in this review article. Result: Seven treatment areas were identified: Anti-inflammatory, Immunomodulatory, Endocrine suppressor, Tumour suppressor, Glut-1 inhibitor, Aromatase inhibitor, and Lectin-containing plants. Among the molecular targets, 51 % (33/64) caused apoptosis and 37 % (24/64) demonstrated cell proliferation activity. The review provides evidence of data suggesting that 17 % therapeutic targets have carcinogen inactivation activity, 10 % have precancerous growth prevention activity, 9% have mutagenesis and gene expression activity, and 4 % regulate toxic metabolism. Conclusion: Ayurvedic herbs that suppress multiple pathways must be chosen for prevention as well as treatment of the disease. It may not only be beneficial in reducing the harms of chemotherapeutic agents but also enhances their efficacy as supportive care.
引用
收藏
页数:17
相关论文
共 94 条
[1]   Selective Estrogen Receptor Modulator and prostimulatory effects of phytoestrogen beta-ecdysone in Tinospora cordifolia on osteoblast cells [J].
Abiramasundari, Ganesan ;
Gowda, M. Mohan ;
Sreepriya, Meenakshisundaram .
JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, 2018, 9 (03) :161-168
[2]   From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer [J].
Aggarwal, BB ;
Ichikawa, H ;
Garodia, P ;
Weerasinghe, P ;
Sethi, G ;
Bhatt, ID ;
Pandey, MK ;
Shishodia, S ;
Nair, MG .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (01) :87-118
[3]  
Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
[4]   Oxidative stress mediated cytotoxicity of tin (IV) oxide (SnO2) nanoparticles in human breast cancer (MCF-7) cells [J].
Ahamed, Maqusood ;
Akhtar, Mohd Javed ;
Khan, M. A. Majeed ;
Alhadlaq, Hisham A. .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2018, 172 :152-160
[5]   Awareness and current knowledge of breast cancer [J].
Akram, Muhammad ;
Iqbal, Mehwish ;
Daniyal, Muhammad ;
Khan, Asmat Ullah .
BIOLOGICAL RESEARCH, 2017, 50
[6]  
Al M., 2012, BREAST CANCER RES TR, V136, P1, DOI [10.1007/s10549-012-2289-9, DOI 10.1007/S10549-012-2289-9]
[7]   Survivin and IAP proteins in cell-death mechanisms [J].
Altieri, Dario C. .
BIOCHEMICAL JOURNAL, 2010, 430 :199-205
[8]   Physicochemical investigations of biogenic chitosan-silver nanocomposite as antimicrobial and anticancer agent [J].
Arjunan, Nithya ;
Kurnari, Henry Linda Jeeva ;
Singaravelu, Chandra Mohan ;
Kandasamy, Ruckmani ;
Kandasamy, Jothivenkatachalarn .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 92 :77-87
[9]   Tibetan Medicine for Cancer: An Overview and Review of Case Studies [J].
Bauer-Wu, Susan ;
Lhundup, Tenzin ;
Tidwell, Tawni ;
Lhadon, Tenzin ;
Ozawa-de Silva, Chikako ;
Dolma, Jamyang ;
Dorjee, Pema ;
Neshar, Dorjee Rapten ;
Sangmo, Rigzin ;
Yeshi, Tenzin .
INTEGRATIVE CANCER THERAPIES, 2014, 13 (06) :502-512
[10]  
Cha S.S., 2016, HHS PUBLIC ACCESS, V11, P184, DOI [10.3109/19390211.2013.859220.The, DOI 10.3109/19390211.2013.859220.THE]